Safpime 250mg Injection
Marketer
Safetech Formulation
Salt Composition
Cefepime (250mg)
Overview Safpime 250mg Injection
Cefpime 250mg injection is a powerful antibacterial agent effective against various bacteria. It's indicated for serious bacterial infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, and bloodstream. Its mechanism involves bacterial cell death, thus resolving the infection. Importantly, it's ineffective against viral infections. Cefpime 250mg injection is frequently administered to critically ill hospitalized patients. Intravenous administration, either by infusion or direct injection, is strictly under medical or nursing supervision. Dosage is individualized based on infection severity, location, and type. Complete the prescribed treatment course, even with rapid symptom improvement; premature discontinuation risks relapse or worsening infection. Potential side effects include skin rash, pruritus, nausea, emesis, cephalalgia, pyrexia, diarrhea, and localized injection site erythema and edema. These are usually transient, resolving spontaneously. Report persistent or bothersome side effects to your physician. Prior to treatment, disclose any kidney or liver impairment, or antibiotic allergies. Regular blood tests to monitor renal function may be recommended. Generally considered safe during pregnancy and lactation under medical guidance.
Primary Ingredients of Safpime 250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Safpime 250mg Injection
Managing life-threatening bacterial infections
Major Benefits of Safpime 250mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Safpime 250mg Injection:
- Injection site reactions (pain, swelling, redness)
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
- Increased prothrombin time
- Decreased phosphate level in blood
- Increased partial thromboplastin time (PTT)
How to use Safpime 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Safpime 250mg Injection works:
Cefpime 250mg Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Safpime 250mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication safpime (250mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Cefpirome 250mg Injection poses minimal breastfeeding risk. Research in humans indicates negligible transfer to breast milk, presenting no apparent infant harm. However, extended Safpime 250mg Injection use should be avoided due to potential side effects like skin rashes and loose stools.
DrivingCONSULT YOUR DOCTOR
The impact of a 250mg Safpime injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function require careful monitoring when administered Safpime 250mg Injection. Dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Safpime 250mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Safpime 250mg Injection :
Omit a Safpime 250mg Injection dose? Seek medical advice.
Facts to Know About Safpime 250mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Extended-spectrum cephalosporins (third and fourth generation) |
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
| Actions | Fourth-Generation Cephalosporins |
3,018 People bought this recently